For example, insulin resistance is emerging as a key indicator of Alzheimers disease and Parkinsons disease
GLP-1 Receptor Agonist Market Segment Analysis By Product, Ozempic dominated with ~35.12% share in 2025
Heres how Rybelsus works, common side effects, cost considerations, and when you can potentially expect more GLP-1 oral medications to hit the market
Serious complications like pancreatitis or gallbladder issues are rare but should prompt immediate consultation with a healthcare professional
Effect of the glucagon-like peptide-1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: a randomized trial in adults with obesity and prediabetes